AI generated summary of Pubmed citation/abstract with PMID 38093418

https://pubmed.ncbi.nlm.nih.gov/38093418

Metadherin decreases chemosensitivity of triple-negative breast cancer to paclitaxel by activating the AKT/GSK-3β signaling pathway, thereby worsening disease-free survival.